BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 1999

View Archived Issues

CRCT and Duke receive US BRCA2 gene patent

Read More

BioSpecifics announces results of injectable collagenase phase II study

Read More

Schering Berlin completes acquisition of Diatide

Read More

SmithKline Beecham licenses antigen technology from Cortecs

Read More

Nasonex Nasal Spray approved in E.U. for use in young children

Read More

Vasogen study shows VasoCare therapy improves blood flow in patients with PVD

Read More

Zeria evaluates potential cognition enhancer in healthy volunteers

Read More

Interim data fom phase II IntraDose trial in liver cancer indicate positive response

Read More

Glaxo Wellcome files for approval of new Relenza indications: influenza prophylaxis, pediatric use

Read More

Pharmacia & Upjohn describes anthracycline glycosides and their antitumor activity

Read More

Azacycloalkane derivatives from Sanofi-Synthelabo with dual hypoglycemic/antiinflammatory actions

Read More

Dopaminergic compounds disclosed by AHP for Parkinson's disease, schizophrenia, etc.

Read More

Newly issued patent covers Esteve's novel analgesic agents

Read More

Amgen's epoetin alfa approved in children with chronic renal failure

Read More

Antiviral agents discovered at U. of Michigan

Read More

Alpha2-adrenoceptor ligands from Ortho-McNeil with analgesic and other pharmacological effects

Read More

Landmark study in type II diabetics assesses long-term efficacy of Avandia

Read More

Potential interaction between S-4661 and valproic acid

Read More

Metabolism of S-2150 elucidated in two studies presented at Xenobiotics meeting

Read More

Inhibitex enters collaboration with ZLB for S. aureus antiinfective agents

Read More

TKS-159: metabolism of new GI prokinetic agent and comparison with other benzamides

Read More

Novartis presents phase I results for transplant drug at ASN

Read More

Idun identifies X-ray structure of caspase 8

Read More

Novel class of bifunctional anticancer agents discovered at University of Kansas

Read More

Visudyne submitted for marketing approval in Canada

Read More

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Read More

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Read More

Stabilized 99mTc complex RP-463 for imaging infections

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing